BUSINESS CONCENTRATIONS (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Concentration Risk [Line Items]
Revenues	$ 4,417,598	$ 5,535,685	$ 12,653,495	$ 14,869,023
Supplier Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration Risk	100.00%	97.00%	100.00%	97.00%
Customer Concentration Risk [Member] | Sales Revenue [Member] | Pharmacy Innovations PA [Member]
Concentration Risk [Line Items]
Revenues			$ 2,715,000	$ 2,113,000
Customer Concentration Risk [Member] | Sales Revenue [Member] | AmerisourceBergen [Member]
Concentration Risk [Line Items]
Revenues			1,716,000
Customer Concentration Risk [Member] | Sales Revenue [Member] | Cardinal Health [Member]
Concentration Risk [Line Items]
Revenues			1,764,000
Customer Concentration Risk [Member] | Sales Revenue [Member] | McKesson Corporation [Member]
Concentration Risk [Line Items]
Revenues			$ 1,458,000
Customer Concentration Risk [Member] | Sales Revenue [Member] | Woodstock Pharmaceutical and Compounding [Member]
Concentration Risk [Line Items]
Revenues				2,247,000
Customer Concentration Risk [Member] | Sales Revenue [Member] | Medical Center Pharmacy [Member]
Concentration Risk [Line Items]
Revenues				2,683,000
Customer Concentration Risk [Member] | Sales Revenue [Member] | Due West Pharmacy [Member]
Concentration Risk [Line Items]
Revenues				$ 1,890,000
Customer Concentration Risk [Member] | Sales Revenue [Member] | Four Customers [Member]
Concentration Risk [Line Items]
Concentration Risk			60.00%	60.00%
Customer Concentration Risk [Member] | Sales Revenue [Member] | Four Customers [Member] | Minimum [Member]
Concentration Risk [Line Items]
Concentration Risk			10.00%	10.00%